SHR-2173

· Guangdong Hengrui Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for SHR-2173, covering 2025-05-29 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus [Phase 2]